3/19/21 3/19/21 Alliance Statement on Confirmation of HHS Secretary Becerra Read More Analysis and Commentary 3/13/21 Analysis and Commentary 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More Analysis and Commentary 3/6/21 Analysis and Commentary 3/6/21 Critical Supply Chains and the FDA Read More Advocacy at a Glance 3/6/21 Advocacy at a Glance 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More Analysis and Commentary 2/27/21 Analysis and Commentary 2/27/21 Questions (and Answers) About Current Political Issues Read More Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More Analysis and Commentary 2/19/21 Analysis and Commentary 2/19/21 "FDA Exceptionalism," Redux (Again) Read More Advocacy at a Glance 2/19/21 Advocacy at a Glance 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More Analysis and Commentary 2/13/21 Analysis and Commentary 2/13/21 FDA-related Provision of House Reconciliation Bill Read More Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More Analysis and Commentary 2/5/21 Analysis and Commentary 2/5/21 Alliance's "Ask" for FY 22: Member Input Is Requested Read More Advocacy at a Glance 2/5/21 Advocacy at a Glance 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Analysis and Commentary 1/29/21 Analysis and Commentary 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More Advocacy at a Glance 1/29/21 Advocacy at a Glance 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More Analysis and Commentary 1/21/21 Analysis and Commentary 1/21/21 Leadership and FDA Appropriation for FY 22 Read More Advocacy at a Glance 1/22/21 Advocacy at a Glance 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More Analysis and Commentary 1/16/21 Analysis and Commentary 1/16/21 Supporting a Budget Increase for FDA for FY 22 Read More Advocacy at a Glance 1/16/21 Advocacy at a Glance 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More Analysis and Commentary 1/8/21 Analysis and Commentary 1/8/21 Now We Know Who'll Be in Charge Read More Newer Posts Older Posts
Analysis and Commentary 3/13/21 Analysis and Commentary 3/13/21 DMAP: Focusing on a Fundamental Challenge Read More
Advocacy at a Glance 3/13/21 Advocacy at a Glance 3/13/21 COVID relief legislation becomes law, providing $500 million in no-year money to support FDA’s work on COVID and related items. Read More
Analysis and Commentary 3/6/21 Analysis and Commentary 3/6/21 Critical Supply Chains and the FDA Read More
Advocacy at a Glance 3/6/21 Advocacy at a Glance 3/6/21 The Senate has taken up the COVID relief reconciliation bill and is expected to be done before March 8, assuming the Senate will work this weekend if necessary. Read More
Analysis and Commentary 2/27/21 Analysis and Commentary 2/27/21 Questions (and Answers) About Current Political Issues Read More
Advocacy at a Glance 2/28/21 Advocacy at a Glance 2/28/21 The reconciliation legislation, with substantial money to support FDA’s COVID activities, is advancing, but slowly. Read More
Analysis and Commentary 2/19/21 Analysis and Commentary 2/19/21 "FDA Exceptionalism," Redux (Again) Read More
Advocacy at a Glance 2/19/21 Advocacy at a Glance 2/19/21 Senator Tammy Baldwin is the new Chairwoman of the Senate Ag/FDA appropriations subcommittee. Reconciliation is advancing and includes $500 million to support FDA’s COVID activities. Read More
Analysis and Commentary 2/13/21 Analysis and Commentary 2/13/21 FDA-related Provision of House Reconciliation Bill Read More
Advocacy at a Glance 2/13/21 Advocacy at a Glance 2/13/21 Under the House reconciliation bill, FDA would gain $500 million in no-year money to support its COVID-19 activities. The Alliance issued a statement of support for these funds. Read More
Analysis and Commentary 2/5/21 Analysis and Commentary 2/5/21 Alliance's "Ask" for FY 22: Member Input Is Requested Read More
Advocacy at a Glance 2/5/21 Advocacy at a Glance 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
Analysis and Commentary 1/29/21 Analysis and Commentary 1/29/21 Biden's Budget Request for FY 22 and Related Issues Read More
Advocacy at a Glance 1/29/21 Advocacy at a Glance 1/29/21 Representatives Bishop and Fortenberry have been formally named as Chair and Ranking Member, respectively, on the House Appropriations Subcommittee on Ag/FDA. Read More
Analysis and Commentary 1/21/21 Analysis and Commentary 1/21/21 Leadership and FDA Appropriation for FY 22 Read More
Advocacy at a Glance 1/22/21 Advocacy at a Glance 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Analysis and Commentary 1/16/21 Analysis and Commentary 1/16/21 Supporting a Budget Increase for FDA for FY 22 Read More
Advocacy at a Glance 1/16/21 Advocacy at a Glance 1/16/21 Congressional organizing, impeachment, inauguration, and COVID-19 planning are all part of changes in DC. Read More
Analysis and Commentary 1/8/21 Analysis and Commentary 1/8/21 Now We Know Who'll Be in Charge Read More
